Heat-activated intravenous liposomal doxorubicin combined with mitomycin C hyperthermic intravesical chemotherapy (HIVEC) for treatment of bladder cancer.

Saved in:
Bibliographic Details
Title: Heat-activated intravenous liposomal doxorubicin combined with mitomycin C hyperthermic intravesical chemotherapy (HIVEC) for treatment of bladder cancer.
Authors: Mikhail AS; Center for Interventional Oncology, Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Gurram S; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Valera VA; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Haemmerich D; Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina, USA., Gopal N; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Bakhutashvili I; Center for Interventional Oncology, Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Richardson W; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Peer CJ; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Starost MF; Division of Veterinary Resources, National Institutes of Health, Bethesda, Maryland, USA., Hesswani C; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Schmidt KT; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Figg WD; Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Karanian JW; Center for Interventional Oncology, Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Pritchard WF; Center for Interventional Oncology, Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Wood BJ; Center for Interventional Oncology, Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Source: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2026 Dec; Vol. 43 (1), pp. 2615462. Date of Electronic Publication: 2026 Feb 03.
Publication Type: Journal Article; Research Support, N.I.H., Intramural
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8508395 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-5157 (Electronic) Linking ISSN: 02656736 NLM ISO Abbreviation: Int J Hyperthermia Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1464-5157
DOI:10.1080/02656736.2026.2615462